Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Caplin Steriles Secures USFDA Approval for Generic Methylprednisolone Injection

USFDA nod to Alembic Pharma breast cancer injection Fulvestrant

Ruchika Sharma26 Dec 2022 1:15 PM IST

Fulvestrant Injection is an estrogen receptor antagonist indicated for the treatment of breast cancer.

India hopes to conclude trade pact with US this year, finance minister says

India recognised as pharmacy of world as we produce affordable drugs: Finance Minister Nirmala Sitharaman

Ruchika Sharma26 Dec 2022 12:15 PM IST

New Delhi: India is recognised as the pharmacy of the world as the country produces global standard medicine at affordable cost, Union Finance...

Raid: Spurious medical drugs worth Rs 23.22 lakh seized in Odisha

Ruchika Sharma25 Dec 2022 3:15 PM IST

Bhubaneswar: Spurious medical drugs worth Rs 23.22 lakh were seized in Odisha's Cuttack on Friday, a statement said.Raids were conducted by...

Eisai-Biogen Alzheimer's drug Lecanemab should be priced below Aduhelm: Report

Ruchika Sharma25 Dec 2022 2:00 PM IST

Treatment with the drug may provide a small or even substantial benefit to patients with early Alzheimer's, but there remains a possibility of net...

BioNTech begins clinical trial of mRNA-based malaria vaccine candidate

Ruchika Sharma25 Dec 2022 12:15 PM IST

The company said it will initially evaluate different antigens of the parasite that causes malaria over the coming months to help select the...

Lupin Partners with TB Alliance to Advance Telacebec for TB, Leprosy and Buruli Ulcer

Merck, Kelun-Biotech ink pact to develop seven investigational preclinical ADC for cancer treatment

Ruchika Sharma25 Dec 2022 11:00 AM IST

Kelun-Biotech will receive an upfront payment of $175 million from Merck.

Kerala Govt to cancel licences of pharmacies selling antibiotics without prescription

Ruchika Sharma24 Dec 2022 5:00 PM IST

In a statement on Wednesday, the state Health Department said direct purchase of antibiotics from pharmacies without a doctor's prescription is a...

Roche bags USFDA nod for companion diagnostic to identify patients with HER2-ultralow metastatic breast cancer eligible for Enhertu

Roche bags USFDA approval for Lunsumio to treat follicular lymphoma

Ruchika Sharma24 Dec 2022 2:00 PM IST

Follicular lymphoma (FL) is the most common slow-growing (indolent) form of non-Hodgkin lymphoma, accounting for about one in five cases.

Moderna fires back at Pfizer counterclaims in COVID vaccine patent lawsuit

Ruchika Sharma24 Dec 2022 12:30 PM IST

Moderna asked for an undisclosed amount of money damages from Pfizer COVID-19 vaccines sold since March.

Patent infringement: Roche loses US appeal in Sandoz lung disease drug case

Ruchika Sharma24 Dec 2022 11:30 AM IST

San Francisco-based Genentech's Esbriet is used to treat IPF, a serious chronic lung disease. Roche earned over $1 billion last year from worldwide...

Ajanta Pharma Sets Up Wholly Owned Subsidiary in Ireland

Ajanta Pharma Promoter entities sell 4.3 percent stake for Rs 637 crore

Ruchika Sharma24 Dec 2022 10:00 AM IST

New Delhi: Promoter entities of Ajanta Pharma has divested 4.3 percent stake in the company for Rs 637 crore through open market transactions. The...

Gilead Sciences bags USFDA nod for Sunlenca to treat HIV-1 infection

Ruchika Sharma23 Dec 2022 4:09 PM IST

Lenacapavir is a breakthrough innovation with the potential to be a preferred and versatile foundational long-acting agent due to its therapeutic...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok